These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 23445465)

  • 21. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
    Gil IG; Ponte BM; Mateo ST; García JJ
    J Oral Implantol; 2019 Aug; 45(4):289-296. PubMed ID: 31207196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dental endosseous implants in patients on bisphosphonate therapy.
    Scully C; Madrid C; Bagan J
    Implant Dent; 2006 Sep; 15(3):212-8. PubMed ID: 16966893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
    Kwon TG; Lee CO; Park JW; Choi SY; Rijal G; Shin HI
    Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.
    Pavkovic M; Petrushevska G; Jovanovic R; Karanfilski O; Cevreska L; Stankovic S; Stojanovic A
    Prilozi; 2010; 31(2):39-49. PubMed ID: 21258276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopathology induced by bisphosphonates and dental implants: clinical observations.
    Jacobsen C; Metzler P; Rössle M; Obwegeser J; Zemann W; Grätz KW
    Clin Oral Investig; 2013 Jan; 17(1):167-75. PubMed ID: 22415216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates and dental implants: current problems.
    Flichy-Fernández AJ; Balaguer-Martínez J; Peñarrocha-Diago M; Bagán JV
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E355-60. PubMed ID: 19561566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Janovska Z; Mottl R; Slezak R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonate and Implant Dentistry - Is it Safe?
    Thirunavukarasu A; Pinto HG; Seymour KG
    Prim Dent J; 2015 Aug; 4(3):30-3. PubMed ID: 26556516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
    Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
    J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
    Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The rare case of osteonecrosis of the jaws in a patient treated with bisphosphonates for osteoporosis].
    Lewandowski B; Brodowski R; Kość T; Migut M; Wojnar J
    Przegl Lek; 2016; 73(1):46-8. PubMed ID: 27120948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M; Lawson W; Montazem A
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early dental implant failure in patient associated with oral bisphosphonates.
    Gupta R
    Indian J Dent Res; 2012; 23(2):298. PubMed ID: 22945738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.